21st Century Oncology Inc is categorized under Oncologists in Fort Myers, FL and active since 2008.
21st Century Oncology Inc was established in 2008, and today employs 1 to 4, earning $50.000.000 to $99.999.999 per year. This is a Oncologists business, which does work in the B2C market, and is classified as a Oncologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Daniel E Dosoretz at the company’s headquarters by writing to 2270 Colonial Boulevard, Fort Myers, Florida FL 33907 or by phoning (239) 931-7275. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | 21st Century Oncology Inc |
| Contact Person: | Daniel E Dosoretz |
| Address: | 2270 Colonial Boulevard, Fort Myers, Florida 33907 |
| Phone Number: | (239) 931-7275 |
| Website Address: | rtsx.com |
| Annual Revenue (USD): | $50.000.000 to $99.999.999 |
| Founded: | 2008 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Oncologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
21st Century Oncology Inc was started in 2008 to provide professional Oncologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000.000 to $99.999.999 per annum.
Feel free to contact Daniel E Dosoretz for inquiries that concern 21st Century Oncology Inc by calling the company number (239) 931-7275, as your correspondence is most welcome. Additionally, the physical location of the headquarters of 21st Century Oncology Inc can be found at the coordinates 26.596868,-81.866188 as well as the street address 2270 Colonial Boulevard in Fort Myers, Florida 33907.
For its online presence, you may visit 21st Century Oncology Inc’s website at rtsx.com and engage with its social media outlets through on Twitter and on Facebook.